Don't expect the US Federal Trade Commission to submit additional warning letters about false claims for cannabidiol-containing consumer health products. That's because the commission will investigate the next firm linked to the noncompliant advertising.
"We've now got six warning letters out there on CBD. The warning letter phase is over. Going forward we will not be issuing warning letters
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?